Airstrikes in Yemen and Iraq this week weighed on the market, and pro David Darst had a warning for investors if more strikes occur.» Read More
Ralph Acampora still thinks the stock market is extended, but he said "everything has changed" since he predicted a correction in May.
TV legend Regis Philbin provides analysis on Micron's quarterly numbers and shares other investment opportunities.
Where is the top state for business in America? CNBC's Scott Cohn explains the process behind the CNBC study and reveals a clue to the winner.
Daniel Curran, University of Dayton president, explains the university's push for the environment and why it divested coal and fossil fuels from its $670 million investment pool.
CNBC.com Managing Editor Allen Wastler reports Buffalo Wild Wings, Google's secretive updates and agricultural tech are the hottest topics on CNBC.com.
Ben Parr, Dominate Fund, weighs in on Google Nest Labs' purchase of Dropcam and whether it is a good move for the company. The "Closing Bell" panel provides perspective.
Lululemon founder Chip Wilson is reportedly working with Goldman Sachs to regain control of the company. Don Peebles, The Peebles Corporation CEO, and Dana Telsey, Telsey Advisory Group CEO, provide perspective.
"Fast Money" trader Steve Grasso provides instant analysis to Micron's quarterly numbers.
Micron is reporting Q3 EPS of $0.79 ex-items on revenue of $3.98 billion, with CNBC's Jon Fortt.
Dissecting current market volatility, with Ralph Acampora, Altaira; Phil Orlando, Federated Investors; Dani Hughes, Divine Capital; and CNBC's Dominic Chu.
Discussing why the Fed is skeptical about the bull rally and what sectors are overvalued, with Jeff Reeves, Investorplace.com editor, and Anthony Chan, Chase chief economist.
The consumer discretionary space has been the worst performing sector this year. CNBC's Seema Mody shows which losing stocks in the index are looking to rebound.
Michael Bonney, Cubist Pharmaceuticals CEO, discusses the FDA's approval of Sivextro, a new antibiotic designed to treat skin infections. Bonney also explains why so many pharma companies have left the antibiotic space.
So far Nike has missed out on the Dow's run to 17,000 and is down significantly versus the S&P. Andrew Keene, Keene on the Market founder, and Ross Gerber, Gerber Kawasaki, discuss if Nike is a buy at these levels.
Discussing how turmoil in Iraq could impact gas prices, with John Hofmeister, former president Shell Oil Company and founder and CEO of Citizens for Affordable Energy. Hofmeister says he is worried about the U.S. taking this event seriously and doing something to protect Americans from volatility and uncertainty.
Secretary of State John Kerry is meeting with Iraqi officials to try and get them to form a new government as ISIS captures more towns. NBC's Ayman Mohyeldin reports the latest from the besieged country.
Discussing how the equity market relates to the underlying economy and if a correction is coming, with Uri Landesman, Platinum Partners; Paul Dietrich, Fairfax Global Partners; and Meg Green, Meg Green & Associates.
CNBC reveals America's Top State for Business on 2014 on Tuesday — not that that stopped Twitter from trying to guess which state topped the list.
What do Elon Musk and Stephen Hawking, two of the great minds of our time fear? The rise of the machines. Their warnings are chilling.
A new Wall Street Journal and NBC News poll has found more Americans are doubting President Obama's competence. "Meet the Press" moderator David Gregory addresses how situations in Iraq have contributed.